Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**BR+NAD** is a proprietary, clinician-administered brain-restoration and addiction-recovery protocol developed at Springfield Wellness Center. Its central intravenous active component is oxidized nicotinamide adenine dinucleotide, with accompanying oral amino-acid, vitamin, and mineral supplementation and variable supportive medications as clinically indicated. The protocol is principally used in treatment programs for alcohol and opioid withdrawal and recovery; reported evidence consists largely of clinic-associated retrospective analyses and follow-up surveys rather than confirmatory randomized controlled trials. ([springfieldwellnesscenter.com](https://springfieldwellnesscenter.com/brplusnad/))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on BR+NAD.